SEC Form 4Coverage since Jul 6, 2026
$ORIC insider trading
Over the last 12 months, Oric Pharmaceuticals insiders reported no purchases and 3 sales totaling $161K across SEC Form 4 filings. 100% of the activity was filed under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $161K 3 events
- Events · 12m
- 3 Form 4 filings, grouped
- Insiders · 12m
- 1 distinct reporters
- 10b5-1 share
- 100% pre-arranged plans
Side
Price · $ORIC · 12Mvia TradingView
Top insiders · 12m
Heyman Richard A.—3× · $161K
All insider trades
3 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 24, 2026 | Heyman Richard A.D | ▼ Sale | 6,100 | $12.02 | $73K | -2.9% | plan · indirect |
| Jul 24, 2026 | Heyman Richard A.D | ▼ Sale | 7,000 | $12.02 | $84K | -15.5% | plan |
| Jul 6, 2026 | Heyman Richard A.D | ▼ Sale | 300 | $12 | $4K | -0.1% | plan · indirect |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $ORIC feed.